You are here

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Methicillin-Resistant Staphylococcus Aureus (MRSA), Hospital-Acquired Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Patients will be enrolled in the study if they fulfill the following three inclusion
criteria:

1. Protocol criteria for HAP/VAP: Criteria for making a correct diagnosis of HAP will be
met if the patient develops a new or progressive pulmonary infiltrate associated with
at least two of the following: new or increased respiratory symptomatology (cough,
sputum or tracheal secretions, shortness of breath), fever or hypothermia,
leukocytosis, left shift, or leukopenia, or deterioration of pulmonary function.

2. Isolation of MRSA from a respiratory sample or blood culture within 48 hours of the
diagnosis of HAP/VAP

3. Treatment of MRSA HAP/VAP with either vancomycin or linezolid with incorporation of
100 patients in the vancomycin arm and 100 patients in the linezolid arm

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Patients not meeting enrollment criteria.

NCT01561469
Pfizer
Completed
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Methicillin-Resistant Staphylococcus Aureus (MRSA), Hospital-Acquired Pneumonia
NCT01561469
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now